These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8718566)

  • 1. Diagnosis and classification of dyslipidemia in renal disease.
    Attman PO; Samuelsson O; Alaupovic P
    Blood Purif; 1996; 14(1):49-57. PubMed ID: 8718566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein metabolism and renal failure.
    Attman PO; Samuelsson O; Alaupovic P
    Am J Kidney Dis; 1993 Jun; 21(6):573-92. PubMed ID: 8503411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of renal failure: role of apolipoprotein B-containing lipoproteins.
    Attman PO; Samuelsson O; Alaupovic P
    Kidney Int Suppl; 1997 Dec; 63():S98-101. PubMed ID: 9407433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal disease.
    Samuelsson O; Attman PO; Knight-Gibson C; Kron B; Larsson R; Mulec H; Weiss L; Alaupovic P
    Nephron; 1997; 75(3):286-94. PubMed ID: 9069450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure.
    Attman PO; Alaupovic P; Tavella M; Knight-Gibson C
    Nephrol Dial Transplant; 1996 Jan; 11(1):63-9. PubMed ID: 8649654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein abnormalities as a risk factor for progressive nondiabetic renal disease.
    Attman PO; Alaupovic P; Samuelsson O
    Kidney Int Suppl; 1999 Jul; 71():S14-7. PubMed ID: 10412728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lipid metabolism abnormalities in Chronic Kidney Disease].
    Bianchi S; Baronti A; Cominotto R; Bigazzi R
    G Ital Nefrol; 2016 Malattie Metaboliche e Rene; 33(S68):. PubMed ID: 27960010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dialysis modalities and dyslipidemia.
    Attman PO; Samuelsson O; Johansson AC; Moberly JB; Alaupovic P
    Kidney Int Suppl; 2003 May; (84):S110-2. PubMed ID: 12694322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into lipid metabolism in the nephrotic syndrome.
    Kaysen GA; de Sain-van der Velden MG
    Kidney Int Suppl; 1999 Jul; 71():S18-21. PubMed ID: 10412729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperlipidemia in chronic kidney disease.
    Kaysen GA
    Int J Artif Organs; 2007 Nov; 30(11):987-92. PubMed ID: 18067100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo kinetic studies to further understand pathogenesis of abnormal lipoprotein metabolism in chronic kidney disease.
    Ikewaki K
    Clin Exp Nephrol; 2014 Apr; 18(2):261-4. PubMed ID: 24129559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of low density lipoproteins in nephrotic dyslipidemia: comparison of hypercholesterolemia alone and combined hyperlipidemia.
    Vega GL; Toto RD; Grundy SM
    Kidney Int; 1995 Feb; 47(2):579-86. PubMed ID: 7723244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in serum lipoproteins in kidney diseases].
    Mordasini R; Riesen W
    Schweiz Med Wochenschr; 1982 Sep; 112(39):1335-40. PubMed ID: 6755693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoalbuminemia increases lysophosphatidylcholine in low-density lipoprotein of normocholesterolemic subjects.
    Vuong TD; Stroes ES; Willekes-Koolschijn N; Rabelink TJ; Koomans HA; Joles JA
    Kidney Int; 1999 Mar; 55(3):1005-10. PubMed ID: 10027937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency.
    Samuelsson O; Attman PO; Knight-Gibson C; Larsson R; Mulec H; Weiss L; Alaupovic P
    J Am Soc Nephrol; 1998 Aug; 9(8):1482-8. PubMed ID: 9697671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyslipidemia of kidney disease.
    Attman PO; Samuelsson O
    Curr Opin Lipidol; 2009 Aug; 20(4):293-9. PubMed ID: 19512921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis].
    Kes P; Reiner Z; Brunetta B
    Lijec Vjesn; 2002; 124(11-12):372-7. PubMed ID: 12679979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
    Chapman MJ; Guérin M; Bruckert E
    Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.